Given that Q has proven to be effective for NSCLC treatment, targeting its derivatives might help in understanding the α7nAChRs-mediated signaling pathways as potential targets for NSCLC treatment. The gene discussed is CHRNA7; the disease is non-small cell lung carcinoma.